Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis

BACKGROUND: Due to limitations associated with clopidogrel following percutaneous coronary intervention (PCI), other newer oral anti-platelet agents are being studied. We aimed to systematically carry out a direct comparison of outcomes observed with prasugrel versus clopidogrel following PCI. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bundhun, Pravesh Kumar, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932806/
https://www.ncbi.nlm.nih.gov/pubmed/29720092
http://dx.doi.org/10.1186/s12872-018-0820-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932806/
https://www.ncbi.nlm.nih.gov/pubmed/29720092
http://dx.doi.org/10.1186/s12872-018-0820-6

Ejemplares similares